ICCC / ImmuCell Corporation - Net Long/Short Value

ImmuCell Corporation
US ˙ NasdaqCM ˙ US4525253062

ICCC / ImmuCell Corporation - Net Long/Short Value
Den här sidan ger nettovärderingarna långa/korta för varje institutionellt innehav som rapporterats via 13F- eller NPORT-anmälningar. För att beräkna nettolångt/kortt värde adderar vi aktievärdet till köpoptionsvärdet och subtraherar säljoptionsvärdet. Fonder som rapporterar kortlånade positioner kommer att rapportera aktievärden som negativa. Långa nettopositioner kommer att ha positiva siffror i kolumnen netto lång/kort, och korta nettopositioner kommer att ha negativa värden i den kolumnen.
Ägare Eget kapitalvärde
($1000)
Call värde
($1000)
Put värde
($1000)
Net Long/Short
($1000)
Citadel Advisors Llc
Jones Financial Companies Lllp
Militia Capital Management LLC
Harbour Investments, Inc.
Renaissance Technologies Llc
Bleichroeder LP
Capital Advisors, Ltd. LLC
Steadtrust LLC
Shufro Rose & Co Llc
Advisor Group Holdings, Inc.
Vanguard Fiduciary Trust Co
Vanguard Capital Management Llc
HighTower Advisors, LLC
Essex Financial Services, Inc.
UBS Group AG
Geode Capital Management, Llc
Strategic Financial Services, Inc,
Mesirow Financial Investment Management, Inc.
Cresset Asset Management, LLC
Advisory Services Network, LLC
Dimensional Fund Advisors Lp
Vanguard Group Inc
BlackRock, Inc.
Northern Trust Corp
Morgan Stanley
Wells Fargo & Company/mn
Bailard, Inc.
Hm Payson & Co
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:IUL 8,50 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista